NOSTRIN: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase
- 21 November 2002
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 99 (26) , 17167-17172
- https://doi.org/10.1073/pnas.252345399
Abstract
Activity and localization of endothelial nitric oxide synthase (eNOS) is regulated in a remarkably complex fashion, yet the complex molecular machinery mastering stimulus-induced eNOS translocation and trafficking is poorly understood. In a search by the yeast two-hybrid system using the eNOS oxygenase domain as bait, we have identified a previously uncharacterized eNOS-interacting protein, dubbed NOSTRIN (for eNOS traffic inducer). NOSTRIN contains a single polypeptide chain of 506-aa residues of 58 kDa with an N-terminal cdc15 domain and a C-terminal SH3 domain. NOSTRIN mRNA is abundant in highly vascularized tissues such as placenta, kidney, lung, and heart, and NOSTRIN protein is expressed in vascular endothelial cells. Coimmunoprecipitation experiments demonstrated the eNOS-NOSTRIN interaction in vitro and in vivo, and NOSTRIN's SH3 domain was essential and sufficient for eNOS binding. NOSTRIN colocalized extensively with eNOS at the plasma membrane of confluent human umbilical venous endothelial cells and in punctate cytosolic structures of CHO-eNOS cells. NOSTRIN overexpression induced a profound redistribution of eNOS from the plasma membrane to vesicle-like structures matching the NOSTRIN pattern and at the same time led to a significant inhibition of NO release. We conclude that NOSTRIN contributes to the intricate protein network controlling activity, trafficking, and targeting of eNOS.Keywords
This publication has 40 references indexed in Scilit:
- Endothelial nitric oxide synthase activity is linked to its presence at cell‒cell contactsBiochemical Journal, 2002
- Rapid Transactivation of the Vascular Endothelial Growth Factor Receptor KDR/Flk-1 by the Bradykinin B2 Receptor Contributes to Endothelial Nitric-oxide Synthase Activation in Cardiac Capillary Endothelial CellsJournal of Biological Chemistry, 2002
- Another activation switch for endothelial nitric oxide synthase: why does it have to be so complicated?Trends in Biochemical Sciences, 2001
- Involvement of PCH family proteins in cytokinesis and actin distributionMicroscopy Research and Technique, 2000
- VEGF Induces Nuclear Translocation of Flk-1/KDR, Endothelial Nitric Oxide Synthase, and Caveolin-1 in Vascular Endothelial CellsBiochemical and Biophysical Research Communications, 1999
- The Endothelial Nitric-oxide Synthase-Caveolin Regulatory CycleJournal of Biological Chemistry, 1998
- Acylation Targets Endothelial Nitric-oxide Synthase to Plasmalemmal CaveolaeJournal of Biological Chemistry, 1996
- Myristoylation of endothelial cell nitric oxide synthase is important for extracellular release of nitric oxideMolecular and Cellular Biochemistry, 1995
- High-Level Expression of G Protein-Coupled Receptors with the Aid of the Semliki Forest Virus Expression SystemJournal of Receptors and Signal Transduction, 1995
- NITRIC OXIDE: A Physiologic Messenger MoleculeAnnual Review of Biochemistry, 1994